Diversified Enterprises’s Novo Nordisk NVO Stock Holding History

Diversified Enterprises’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$390K	Buy	10,278 +983	+11%	+$45.3K	0.02%	310
2026 Q2	$446K	Buy	9,295 +1,382	+17%	+$59.4K	0.02%	261
2026 Q1	$291K	Buy	7,913 +11	+0.1%	+$521	0.02%	326
2025 Q4	$402K	Buy	7,902 +1,386	+21%	+$70.9K	0.02%	249
2025 Q3	$362K	Sell	6,516 -2,191	-25%	-$128K	0.02%	209
2025 Q2	$601K	Buy	8,707 +638	+8%	+$43.4K	0.04%	140
2025 Q1	$560K	Buy	8,069 +1,681	+26%	+$139K	0.05%	148
2024 Q4	$549K	Buy	6,388 +172	+3%	+$18.6K	0.05%	120
2024 Q3	$740K	Buy	+6,216	New	+$829K	0.08%	94

Other funds holding NVO

Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return

Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return

Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return

Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nichols & Pratt Advisers Boston, Massachusetts $1.68B AUM 20.22% 1-Year Est. Return

Corda Investment Management Houston, Texas $1.52B AUM 30.53% 1-Year Est. Return

GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return

Philip James Wealth Mangement Milton, Georgia $906M AUM 30.39% 1-Year Est. Return

Diversified Enterprises's NVO Position: Q3 2026 in Review

Diversified Enterprises increased its Novo Nordisk (NVO) stake by 11% in Q3 2026, buying an estimated $45.3K and bringing the position to 10,278 shares worth $390K. The position accounts for 0.02% of the portfolio, ranked #310.

Diversified Enterprises first reported a position in NVO in Q3 2024 and has held it in 9 quarters since. The position peaked at $740K in Q3 2024. 504 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

Diversified Enterprises held 10,278 shares of Novo Nordisk worth $390K as of Q3 2026.
Diversified Enterprises bought 983 Novo Nordisk shares in Q3 2026, an estimated $45.3K.
Novo Nordisk made up 0.02% of Diversified Enterprises's portfolio in Q3 2026, its #310 holding.
Diversified Enterprises first reported a position in Novo Nordisk in Q3 2024 and has held it in 9 quarters since.
Diversified Enterprises's Novo Nordisk position peaked at $740K in Q3 2024.
504 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Diversified Enterprises's 13F filing for Q3 2026, filed 19 Oct 2026.